 |
Jonathan R. T. Davidson, MD, has financial interests/relationships or affiliations in the form of: Speaker for American Psychiatric Association, Cephalon Inc., Eli Lilly and Company, GlaxoSmithKline, Pfizer Inc., Solvay Pharmaceuticals, Wyeth Pharmaceuticals Research Support from Allergan Inc., Bristol-Myers Squibb, Cephalon Inc., Eli Lilly and Company, Forest Pharmaceuticals, GlaxoSmithKline, Nutrition 21, Organon Inc., Pfizer Inc., PureWorld, Solvay Pharmaceuticals, Wyeth Pharmaceuticals, UCB Pharma, Inc. Consultant for Ancile Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Boots Pharmaceuticals, Cephalon Inc., Eli Lilly and Company, Forest Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Novartis Pharmaceuticals, Organon Inc., Pfizer Inc., Pharmacia, Roche Pharmaceuticals, Solvay Pharmaceuticals, and UCB Pharma, Inc. Drugs Supplied for NIH and Other Studiesfrom Eli Lilly and Company, PureWorld, Pfizer Inc., Schwabe Other Royalties from American Psychiatric Association, Guilford Publications, Penguin Putnam, MultiHealth Systems Inc. Unapproved uses of a commercial product, or use of a product
not yet approved for this purpose will be discussed during this
presentation. |